NASDAQ:PCSA Heatwurx Q3 2025 Earnings Report $1.61 -0.01 (-0.62%) Closing price 10/2/2026 03:56 PM EasternExtended Trading$1.59 -0.02 (-1.06%) As of 10/2/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Heatwurx EPS ResultsActual EPS-$1.75Consensus EPS -$2.00Beat/MissBeat by +$0.25One Year Ago EPSN/AHeatwurx Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AHeatwurx Announcement DetailsQuarterQ3 2025Date11/6/2025TimeBefore Market OpensConference Call DateThursday, November 6, 2025Conference Call Time2:00AM ETUpcoming EarningsHeatwurx's Q3 2026 earnings is estimated for Thursday, October 29, 2026, based on past reporting schedulesConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly Report(10-Q) Heatwurx Earnings HeadlinesProcessa Pharmaceuticals to Participate in Upcoming Investor ConferencesSeptember 1, 2026 | globenewswire.comProcessa Pharmaceuticals, Inc. (PCSA) M&A Call Prepared Remarks TranscriptJuly 29, 2026 | seekingalpha.comElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt without major changes. As former head of the Department of Government Efficiency under President Trump, Musk saw firsthand how looming spending cuts could rattle markets and squeeze 401ks, IRAs, and TSPs. A preserved IRS provision may help everyday investors shield their retirement savings before the next wave of volatility hits.October 4 at 1:00 AM | American Hartford Gold (Ad)PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC.July 29, 2026 | globenewswire.comProcessa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare ConferenceJanuary 12, 2026 | globenewswire.comProcessa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer StudyJanuary 5, 2026 | globenewswire.comSee More Heatwurx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Heatwurx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heatwurx and other key companies, straight to your email. Email Address About HeatwurxHeatwurx (NASDAQ:PCSA) was a pavement-maintenance technology company focused on infrared solutions for repairing asphalt. Its technology was designed to heat and soften existing pavement so damaged areas could be reworked and restored, potentially reducing the need to remove and replace asphalt. The company’s product offerings included infrared asphalt-repair equipment and related materials intended for applications such as pothole repair, utility cuts, seams, and other localized pavement damage. Heatwurx marketed its solutions primarily to road-maintenance contractors, municipalities, and other organizations responsible for maintaining paved surfaces. Public information about Heatwurx’s geographic coverage and leadership is limited. The company is also associated with a historical corporate transition: the public entity formerly connected with Heatwurx later changed its business focus and became Processa Pharmaceuticals, Inc., which trades on the Nasdaq under the symbol PCSA. Accordingly, current information associated with PCSA may not describe Heatwurx’s former asphalt-repair operations.View Heatwurx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street DividedMcCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the Test Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
